Navigation Links
Preimplantation Genetic Diagnosis (PGD) Market is Expected to Reach USD 47.4 Million Globally in 2018: Transparency Market Research

ALBANY, New York, October 29, 2012 /PRNewswire/ --

According to the latest market report published by Transparency Market Research ( "Preimplantation Genetic Diagnosis (PGD) Market - Global Industry Analysis, Market Size, Market Share & Forecast 2012 - 2018," the global pre-implantation genetic diagnosis market was estimated to be worth USD 31.9 million in 2011 and is expected to reach USD 47.4 million in 2018, growing at a CAGR of 6.2% from 2013 to 2018. North America dominates the global demand for PGD, and is expected to account for over 30% of the global market followed by Europe at 28% in 2018.

Browse the full report at 

Some of the major drivers of the global PGD market are increase in the scope of direct to consumer genetic testing methods, increase in the number of cases of genetic diseases, the rising rate of infertility and the efficiency of PGD in assisting successful fetal implantation.  PGD is adjunct to in vitro fertilization (IVF) and is employed for detection of any genetic abnormality in the embryo before it is implanted through IVF.

The major types of PGD testing are for determination of chromosomal abnormalities, detection of aneuploidy, HLA typing, gender selection and others. The major market for PGD exists in developed countries. However, emerging markets in the developing nations of Asia and rest of the world will grow with the advent of genetic diagnosis technology and awareness about prevention of genetic disorders.

Over the last decade, the demand for PGD has grown significantly, mostly owing to the growing awareness regarding the prevention of genetic diseases and the increase in the number of genetic disorders which can be diagnosed through PGD. Major opportunities which can be tapped for inducing further growth of the PGD market are innovations in the field of diagnosis of genetically inherited cancer and innovations in genetic diagnosis.

Related & Recently Published Reports by Transparency Market Research

Prostate Cancer Market

Global Osteoporosis Market

Global Nutraceuticals Product Market

Global Nutraceuticals Ingredients Market

Global Surgical Equipment Industry

COPD Drugs Industry

Global Spectrometry Industry

Circulating Tumor Cells Market

Synthetic Biology Industry

U.S. Vaccine Industry

Insulin Devices Market

Home Health Care Industry

Ecc Procedures Industry

The prime geographical markets for PGD are Europe and North America. It is expected that North America will lead the PGD market in terms of market share and revenue by 2018. Asia and rest of the world will also grow at a fast yet steady pace and make their mark in the global PGD market.

This research is specially designed to estimate and analyze the demand for preimplantation genetic diagnosis in the global market. The research provides in-depth analysis of preimplantation genetic diagnosis service providers, the product sales, segment wise trend analysis and the demand of PGD by geography. High level analysis of the segments of the global PGD market is performed and the report provides detailed analysis, comprehensive historical data and statistically tested forecast of the segments thus covered. A comprehensive assessment of the strategies of the participants of the market and the winning imperatives for them has been analyzed by segmenting the global preimplantation genetic diagnosis market as below:

Preimplantation genetic diagnosis market by product types

- For determination of chromosomal abnormalities

- Aneuploidy

- HLA typing

- Gender selection

- X-linked diseases

- Single gene disorders

- Other genetic disorders


Preimplantation genetic diagnosis market by application

- Determination of HLA compatible embryos for stem cell therapy

- Late-onset genetic disorders

- Improving prognosis for in vitro fertilization patients

- Inherited genetic diseases

- Others

In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

- North America

- Europe

- Asia

- Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports

Upcoming Reports in Pharmaceutical Market

Membrane Bioreactor (MBR) Market

Smart Pill Technology Market

Biosimulation Market

Bioinformatics Market

Neuromodulation Devices Market

Hormone Replacement Therapy Market

Agricultural Biotechnology Market

Acute Myeloid Leukemia (AML) Therapeutics Market

Freeze Drying Equipment Market

Antibiotic Market

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Search Reports: 

SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Interleukin Genetics Reports Third Quarter 2011 Financial Results
2. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
3. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Cytogenetics - Technologies, Markets and Companies
6. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
7. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
8. deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
9. GeneThera, Inc. Acquires Applied Genetics, S.A.
10. Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
Breaking Biology News(10 mins):